Abdulrahman S. Altowaim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdulrahman S. Altowaim has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Abdulaziz Mohammed Alghamdi
Department of Otolaryngology–Head and Neck Surgery, King Fahad Military Medical Complex, Dhahran, Saudi Arabia
1 shared publication- Abdulaziz T. Alturki
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
1 shared publication - Abdulrahman A. Bin Moammar
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
1 shared publication - Ali A. Alaklabi
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
1 shared publication - Hassan S. Alqahtani
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia
1 shared publication Lenah Khalid Al Fadhil
Department of Otolaryngology–Head and Neck Surgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (10) , 4196-4200
Unusual location of sinonasal ossifying fibroma of the posterior ethmoid sinus: a case report and literature review
Introduction and importance: Ossifying fibroma is a benign, well-demarcated fibro-osseous neoplasm that most commonly affects the mandible and maxilla. Involvement of the paranasal sinuses is rare, and ethmoid sinus localization is particularly uncommon. Because sinonasal ossifying fibroma may mimic other fibro-osseous and osseous lesions radiologically, histopathologic confirmation and complete excision are important for diagnosis and disease control. Case presentation: A 43-year-old Saudi man with well-controlled type 2 diabetes mellitus presented with a 6-month history of progressive right-sided nasal obstruction and frontal headache. He reported no history of epistaxis, visual disturbance, or anosmia. Computed tomography demonstrated a well-defined 2.5 × 1.6 × 2.3 cm sclerotic lesion with ground-glass matrix occupying the right posterior ethmoid air cells and abutting the skull base. Histopathology confirmed ossifying fibroma. The patient underwent complete endoscopic transnasal resection with skull base repair using a free autologous cartilage graft. The clinical course is summarized in Table 1. Recovery was uneventful, and he was discharged on postoperative day two. Clinical discussion: Ethmoidal ossifying fibroma is rare and may present with nonspecific sinonasal symptoms. Complete excision is recommended for symptomatic sinonasal disease because incomplete removal is associated with recurrence. In selected cases, an endoscopic approach can provide direct visualization, avoid external approach-related morbidity, and allow skull base reconstruction when required. However, 4-month follow-up is insufficient to make definitive statements about long-term recurrence. Conclusion: Posterior ethmoid ossifying fibroma is an uncommon presentation of a benign fibro-osseous tumor. Accurate diagnosis requires clinical, radiologic, and histopathologic correlation. Complete endoscopic resection with appropriate skull base repair can achieve favorable short-term outcomes in selected cases, but prolonged surveillance is necessary.
- 9 September 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (10) , 4196-4200
Open AccessUnusual location of sinonasal ossifying fibroma of the posterior ethmoid sinus: a case report and literature review
Introduction and importance: Ossifying fibroma is a benign, well-demarcated fibro-osseous neoplasm that most commonly affects the mandible and maxilla. Involvement of the paranasal sinuses is rare, and ethmoid sinus localization is particularly uncommon. Because sinonasal ossifying fibroma may mimic other fibro-osseous and osseous lesions radiologically, histopathologic confirmation and complete excision are important for diagnosis and disease control. Case presentation: A 43-year-old Saudi man with well-controlled type 2 diabetes mellitus presented with a 6-month history of progressive right-sided nasal obstruction and frontal headache. He reported no history of epistaxis, visual disturbance, or anosmia. Computed tomography demonstrated a well-defined 2.5 × 1.6 × 2.3 cm sclerotic lesion with ground-glass matrix occupying the right posterior ethmoid air cells and abutting the skull base. Histopathology confirmed ossifying fibroma. The patient underwent complete endoscopic transnasal resection with skull base repair using a free autologous cartilage graft. The clinical course is summarized in Table 1. Recovery was uneventful, and he was discharged on postoperative day two. Clinical discussion: Ethmoidal ossifying fibroma is rare and may present with nonspecific sinonasal symptoms. Complete excision is recommended for symptomatic sinonasal disease because incomplete removal is associated with recurrence. In selected cases, an endoscopic approach can provide direct visualization, avoid external approach-related morbidity, and allow skull base reconstruction when required. However, 4-month follow-up is insufficient to make definitive statements about long-term recurrence. Conclusion: Posterior ethmoid ossifying fibroma is an uncommon presentation of a benign fibro-osseous tumor. Accurate diagnosis requires clinical, radiologic, and histopathologic correlation. Complete endoscopic resection with appropriate skull base repair can achieve favorable short-term outcomes in selected cases, but prolonged surveillance is necessary.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Aging Research
- Vol. 2025 (1) , 6989003
Prevalence of Iron Deficiency Anaemia in Elderly Aged > 60 Taking Daily Low‐Dose Aspirin
Iron deficiency anaemia (IDA) and anaemia of chronic disease are both common causes of morbidity in the elderly population, where they increase hospitalization and mortality. The risk of IDA is increased in gastrointestinal bleeding caused by aspirin at low doses administered daily, which has been widely used to prevent cardiovascular diseases. The current research will compare the occurrence of IDA between patients under 81 mg of low‐dose aspirin and nonaspirin users. The electronic medical records were reviewed for a retrospective cohort study in the King Abdulaziz Medical City, Riyadh, Saudi Arabia (2016–2023). The inclusion criteria were patients aged over 60 years who were taking 81 mg aspirin daily, and 1308 patients were included (654 aspirin users and 654 nonusers). The number of men using aspirin was 378 (56.5), and those not using it were 291 (43.5). The number of women using aspirin was 276 (43.2), and those not using it were 363 (56.8). In the IDA cases, there were 136 (20.8) and 165 (25.2) cases in aspirin and nonaspirin users, respectively. Although this was not a significant difference, the load of haemoglobin in aspirin users was markedly less with a high concentration of ferritin in the bloodstream than in nonusers. Hypertension was a risk factor for IDA. The IDA rates were higher in nonaspirin users in females, old patients and chronic steroid users. Aspirin and nonaspirin users did not differ significantly in terms of IDA incidence. Nonetheless, there were a decreased haemoglobin and an increased ferritin in aspirin users. Potential confounders may include age and BMI, which need to be considered when monitoring low‐dose aspirin patients in old age.
- 1 January 2025
- Published by Wiley in Journal of Aging Research
- Vol. 2025 (1) , 6989003
Open AccessPrevalence of Iron Deficiency Anaemia in Elderly Aged > 60 Taking Daily Low‐Dose Aspirin
Iron deficiency anaemia (IDA) and anaemia of chronic disease are both common causes of morbidity in the elderly population, where they increase hospitalization and mortality. The risk of IDA is increased in gastrointestinal bleeding caused by aspirin at low doses administered daily, which has been widely used to prevent cardiovascular diseases. The current research will compare the occurrence of IDA between patients under 81 mg of low‐dose aspirin and nonaspirin users. The electronic medical records were reviewed for a retrospective cohort study in the King Abdulaziz Medical City, Riyadh, Saudi Arabia (2016–2023). The inclusion criteria were patients aged over 60 years who were taking 81 mg aspirin daily, and 1308 patients were included (654 aspirin users and 654 nonusers). The number of men using aspirin was 378 (56.5), and those not using it were 291 (43.5). The number of women using aspirin was 276 (43.2), and those not using it were 363 (56.8). In the IDA cases, there were 136 (20.8) and 165 (25.2) cases in aspirin and nonaspirin users, respectively. Although this was not a significant difference, the load of haemoglobin in aspirin users was markedly less with a high concentration of ferritin in the bloodstream than in nonusers. Hypertension was a risk factor for IDA. The IDA rates were higher in nonaspirin users in females, old patients and chronic steroid users. Aspirin and nonaspirin users did not differ significantly in terms of IDA incidence. Nonetheless, there were a decreased haemoglobin and an increased ferritin in aspirin users. Potential confounders may include age and BMI, which need to be considered when monitoring low‐dose aspirin patients in old age.